what semaglutide Most people think GLP1 medication works because it slows your stomach and makes you nauseous enough to eat less. Both of those are wrong. We have the data. Here's what's actually happening

Most conversations around GLP 1s focus on the scale, but there's more happening beneath the surface. Data from large scale clinical trials suggests these therapies may influence broader cardiometabolic health markersreinforcing that weight is FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing Beyond GLP 1: the next wave of weight loss medication innovation The Pharmaceutical Journal Glucagon like peptide 1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system British Journal of Anaesthesia